Pulmonary embolism, coffee, when DOACs don’...
In this week’s podcast, John Mandrola, MD, ...
The safety of very low LDL-C, the win-ratio a...
A potential new anticoagulant, surveillance s...
A second ESC review covering REVIVED, the DAN...
Early rhythm control in AF, treating coronary...
The obesity paradox in AF and paradoxes in ge...
AF screening; sodium, potassium, BP, and CV o...
Hyperkalemia in heart failure, CV health in A...
A big new HF and EP trial, doctors and probab...